Prof Peter Jepsen (Henning Grønbæk, Peter Jepsen)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 47

Top Venues

Hepatology communications

Clinical epidemiology

Liver international : official journal of the International Association for the Study of the Liver

Alimentary pharmacology & therapeutics

Aarhus University Hospital

Aarhus University, HEALTH (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aarhus University Hospital Dec 01 2016

Denmark

Specialist in hepatology ("afdelingslæge") :: Department of Hepatology and Gastroenterology

University of Nottingham Aug 01 2016

United Kingdom

Honorary clinical associate professor :: School of Medicine

Aarhus University Hospital Dec 01 2015

Denmark

Associate professor :: Department of Clinical Epidemiology

Education History

Aarhus University, HEALTH

Denmark

PHD

Publications

Elliot B Tapper, Beanna Martinez, Prof Peter Jepsen, Xi Chen, Neehar D Parikh
Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial. Alimentary pharmacology & therapeutics (2024)
Lotte Sahin Levison, Prof Peter Jepsen, Henning Andersen
Registration of Amyotrophic Lateral Sclerosis: Validity in the Danish National Patient Registry. Clinical epidemiology 16 (2024)
Lisbet Grønbaek, Harmony Omeife, Lu Ban, Colin J Crooks, Timothy R Card, Prof Peter Jepsen, Prof Joe West
Smoking is a Risk Factor for Autoimmune Hepatitis: An English Registry-Based Case-Control Study. Clinical epidemiology 16 (2024)
Axel Wester, Prof Peter Jepsen, Hannes Hagström
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Morten Daniel Jensen, Prof Joe West, Colin J Crooks, Joanne R Morling, Frederik Kraglund, Timothy R Card, Gro Askgaard, Prof Peter Jepsen
Primary liver cancer risk and mortality in patients with alcohol-related cirrhosis in England and Denmark: observational cohort studies. The American journal of gastroenterology (2024)
Rasmus Hvidbjerg Gantzel, Emilie E Møller, Niels K Aagaard, Hugh Watson, Henning Grønbæk, Prof Peter Jepsen
Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites. Hepatology communications 8 (7) (2024)
Lotte Sahin Levison, Prof Peter Jepsen, Henning Andersen
Registration of Amyotrophic Lateral Sclerosis: Validity in the Danish National Patient Registry. Clinical epidemiology 16 (2024)
Frederik Kraglund, Nikolaj Skou, Gerda Elisabeth Villadsen, Prof Peter Jepsen
Landmark analysis of the risk of recurrence after resection or ablation for HCC: A nationwide study. Hepatology communications 8 (7) (2024)
Frederik Kraglund, Nikolaj Skou, Gerda Elisabeth Villadsen, Prof Peter Jepsen
Landmark analysis of the risk of recurrence after resection or ablation for HCC: A nationwide study. Hepatology communications 8 (7) (2024)
Elliot B Tapper, Beanna Martinez, Prof Peter Jepsen, Xi Chen, Neehar D Parikh
Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial. Alimentary pharmacology & therapeutics 60 (5) (2024)
Rasmus Hvidbjerg Gantzel, Emilie E Møller, Niels K Aagaard, Hugh Watson, Henning Grønbæk, Prof Peter Jepsen
Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites. Hepatology communications 8 (7) (2024)
Lisbet Grønbaek, Harmony Omeife, Lu Ban, Colin J Crooks, Timothy R Card, Prof Peter Jepsen, Prof Joe West
Smoking is a Risk Factor for Autoimmune Hepatitis: An English Registry-Based Case-Control Study. Clinical epidemiology 16 (2024)
Rasmus Hvidbjerg Gantzel, Emilie E Møller, Niels K Aagaard, Hugh Watson, Henning Grønbæk, Prof Peter Jepsen
Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites. Hepatology communications 8 (7) (2024)
Axel Wester, Prof Peter Jepsen, Hannes Hagström
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Elliot B Tapper, Beanna Martinez, Prof Peter Jepsen, Xi Chen, Neehar D Parikh
Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial. Alimentary pharmacology & therapeutics 60 (5) (2024)
Frederik Kraglund, Nikolaj Skou, Gerda Elisabeth Villadsen, Prof Peter Jepsen
Landmark analysis of the risk of recurrence after resection or ablation for HCC: A nationwide study. Hepatology communications 8 (7) (2024)
Elliot B Tapper, Beanna Martinez, Prof Peter Jepsen, Xi Chen, Neehar D Parikh
Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial. Alimentary pharmacology & therapeutics 60 (5) (2024)
Lars Bossen, Tobias Stemann Lau, Mette Bak Nielsen, Marlene Christina Nielsen, Astrid Højmark Andersen, Peter Ott, Sabine Becker, Henning Glerup, Lise Svenningsen, Martin Eivindson, Linda Skibsted Kornerup, Niels Bjørndal Kjeldsen, Anders Neumann, Holger Jon Møller, Prof Peter Jepsen, Henning Grønbæk
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis. Hepatology communications 7 (4) (2023)
Prof Peter Jepsen, Prof Joe West, Anna Emilie Kann, Frederik Kraglund, Joanne R Morling, Colin J Crooks, Gro Askgaard
Risk of alcohol-associated liver disease in the offspring of parents with alcohol-associated liver disease: A nationwide cohort study. Hepatology (Baltimore, Md.) (2023)
Morten Daniel Jensen, Hugh Watson, Hendrik Vilstrup, Prof Peter Jepsen
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study. Clinical epidemiology 15 (2023)
Prof Peter Jepsen, Prof Joe West, Anna Emilie Kann, Frederik Kraglund, Joanne R Morling, Colin J Crooks, Gro Askgaard
Risk of alcohol-associated liver disease in the offspring of parents with alcohol-associated liver disease: A nationwide cohort study. Hepatology (Baltimore, Md.) 80 (2) (2023)
Marine Sølling Ramsing, Frederik Kraglund, Prof Peter Jepsen
Prevalence of Statin Use and Predictors of Statin Initiation Among Patients with Alcohol-Related Cirrhosis - A Danish Nationwide Cohort Study. Clinical epidemiology 15 (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda Elisabeth Villadsen, Prof Joe West, Prof Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Lars Bossen, Tobias Stemann Lau, Mette Bak Nielsen, Marlene Christina Nielsen, Astrid Højmark Andersen, Peter Ott, Sabine Becker, Henning Glerup, Lise Svenningsen, Martin Eivindson, Linda Skibsted Kornerup, Niels Bjørndal Kjeldsen, Anders Neumann, Holger Jon Møller, Prof Peter Jepsen, Henning Grønbæk
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis. Hepatology communications 7 (4) (2023)
Frederik Kraglund, Gerda Elisabeth Villadsen, Prof Peter Jepsen
Effects of Curative-Intent Treatments on Hepatocellular Carcinoma Survival in Alcohol-Related Cirrhosis: A Nationwide Study. Clinical epidemiology 15 (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda Elisabeth Villadsen, Prof Joe West, Prof Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda Elisabeth Villadsen, Prof Joe West, Prof Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Lars Bossen, Tobias Stemann Lau, Mette Bak Nielsen, Marlene Christina Nielsen, Astrid Højmark Andersen, Peter Ott, Sabine Becker, Henning Glerup, Lise Svenningsen, Martin Eivindson, Linda Skibsted Kornerup, Niels Bjørndal Kjeldsen, Anders Neumann, Holger Jon Møller, Prof Peter Jepsen, Henning Grønbæk
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis. Hepatology communications 7 (4) (2023)
Morten Daniel Jensen, Hugh Watson, Hendrik Vilstrup, Prof Peter Jepsen
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study. Clinical epidemiology 15 (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda Elisabeth Villadsen, Prof Joe West, Prof Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Frederik Kraglund, Gerda Elisabeth Villadsen, Prof Peter Jepsen
Effects of Curative-Intent Treatments on Hepatocellular Carcinoma Survival in Alcohol-Related Cirrhosis: A Nationwide Study. Clinical epidemiology 15 (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda Elisabeth Villadsen, Prof Joe West, Prof Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Rasmus Hvidbjerg Gantzel, Niels Kristian Aagaard, Hendrik Vilstrup, Hugh Watson, Henning Grønbæk, Prof Peter Jepsen
Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality. Hepatology communications 6 (11) (2022)
Weiqi Liao, Prof Peter Jepsen, Carol Coupland, Hamish Innes, Philippa Clare Matthews, Cori Campbell, Eleanor Barnes, Julia Hippisley-Cox, null null
Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the QResearch® database: research protocol and statistical analysis plan. Diagnostic and prognostic research 6 (1) (2022)
Andreas Ladefoged Ebbehøj, Esben Søndergaard, Prof Peter Jepsen, Kirstine Stochholm, Helene Matilde Lundsgaard Svane, Morten Madsen, Per Løgstrup Poulsen, Jens Otto Lunde Jørgensen
The Socioeconomic Consequences of Cushing's Syndrome: A Nationwide Cohort Study. The Journal of clinical endocrinology and metabolism 107 (7) (2022)
Rasmine Birn-Rydder, Morten Daniel Jensen, Prof Peter Jepsen, Lisbet Grønbaek
Extrahepatic autoimmune diseases in autoimmune hepatitis: Effect on mortality. Liver international : official journal of the International Association for the Study of the Liver 42 (11) (2022)
Prof Peter Jepsen, Elliot B Tapper, Thomas Deleuran, Konstantin Kazankov, Gro Askgaard, Henrik Toft Sørensen, Hendrik Vilstrup, Joe West
Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation-wide Cohort Study. Hepatology (Baltimore, Md.) 74 (5) (2021)
Frederik Kraglund, Thomas Deleuran, Gro Askgaard, Kate M Fleming, Prof Peter Jepsen
Decreasing Incidence of Alcohol-Related Liver Disease in Denmark: A 25-Year Nationwide Study. Clinical epidemiology 13 (2021)
Lars Bossen, Paola Rebora, Francesca Bernuzzi, Prof Peter Jepsen, Alessio Gerussi, Pietro Andreone, Andrea Galli, Benedetta Terziroli, Domenico Alvaro, Giancarlo Labbadia, Chiara Aloise, Leonardo Baiocchi, Edoardo Giannini, Ludovico Abenavoli, Pierluigi Toniutto, Fabio Marra, Marco Marzioni, Grazia Niro, Annarosa Floreani, Holger J Møller, Maria G Valsecchi, Marco Carbone, Henning Grønbaek, Invernizzi Pietro
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Lisbet Grønbaek, Harmony Otete, Lu Ban, Colin Crooks, Timothy Card, Prof Peter Jepsen, Joe West
Incidence, prevalence and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study. Liver international : official journal of the International Association for the Study of the Liver 40 (7) (2020)
Prof Peter Jepsen, Hugh Watson, Stewart Macdonald, Hendrik Vilstrup, Rajiv Jalan
MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascites. Alimentary pharmacology & therapeutics 52 (3) (2020)
Morten Daniel Jensen, Torsten Lauritzen, Hendrik Vilstrup, Prof Peter Jepsen
Alanine Aminotransferase and 20-Year Risk of Major Chronic Diseases and Death in a Healthy Cohort Aged 30 to 49 Years. Clinical epidemiology 12 (2020)
Lisbet Grønbaek, Hendrik Vilstrup, Prof Peter Jepsen
Editorial: severe outcomes are rare in pregnancy in autoimmune hepatitis-Authors' reply. Alimentary pharmacology & therapeutics 48 (9) (2019)
Gitte Dam, Hendrik Vilstrup, Per Kragh Andersen, Lars Bossen, Hugh Watson, Prof Peter Jepsen
Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites. Liver international : official journal of the International Association for the Study of the Liver 39 (3) (2018)
Lisbet Grønbaek, Hendrik Vilstrup, Lars Pedersen, Prof Peter Jepsen
Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study. Liver international : official journal of the International Association for the Study of the Liver 39 (1) (2018)
Stewart Macdonald, Prof Peter Jepsen, Laith Alrubaiy, Hugh Watson, Hendrik Vilstrup, Rajiv Jalan
Quality of life measures predict mortality in patients with cirrhosis and severe ascites. Alimentary pharmacology & therapeutics 49 (3) (2018)
Prof Peter Jepsen, Jakob Christensen, Karin Weissenborn, Hugh Watson, Hendrik Vilstrup
Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study. BMC gastroenterology 16 (1) (2016)

Prof Peter Jepsen.css-eqlu8i{font-size:small;padding-left:4px;} (Henning Grønbæk, Peter Jepsen)

Publication Activity (10 Years)

Top Topics

Top Venues

Prof Peter Jepsen (Henning Grønbæk, Peter Jepsen)